Constitutive expression and phenobarbital modulation of drug metabolizing enzymes and related nuclear receptors in cattle liver and extra-hepatic tissues

References

• Alnouti Y, Klaassen CD. (2006). Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93:242–255.
   PubMed Web of Science ®Google Scholar
• Alnouti Y, Klaassen CD. (2008). Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J Pharmacol Exp Ther 324:612–621.
   PubMed Web of Science ®Google Scholar
• Antonovic L, Martinez M. (2011). Role of the cytochrome P450 enzyme system in veterinary pharmacokinetics: where are we now? Where are we going? Future Med Chem 3:855–879.
   PubMed Web of Science ®Google Scholar
• Audet-Walsh E, Auclair-Vincent S, Anderson A. (2009). Glucocorticoids and phenobarbital induce murine CYP2B genes by independent mechanisms. Expert Opin Drug Metab Toxicol 5:1501–1511.
   PubMed Web of Science ®Google Scholar
• Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD. (1994). A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 14:1544–1552.
   PubMed Web of Science ®Google Scholar
• Bell AW, Michalopoulos GK. (2006). Phenobarbital regulates nuclear expression of HNF-4alpha in mouse and rat hepatocytes independent of CAR and PXR. Hepatology 44:186–194.
   PubMed Web of Science ®Google Scholar
• Bellemare J, Rouleau M, Harvey M, Popa I, Pelletier G, Têtu B, Guillemette C. (2011). Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans. J Pathol 223:425–435.
   PubMed Web of Science ®Google Scholar
• Bergheim I, Bode C, Parlesak A. (2005). Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa. BMC Clin Pharmacol 5:4.
   PubMedGoogle Scholar
• Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I. (2007). Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731–742.
   PubMed Web of Science ®Google Scholar
• Buckley DB, Klaassen CD. (2009). Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37:847–856.
   PubMed Web of Science ®Google Scholar
• Bulera SJ, Eddy SM, Ferguson E, Jatkoe TA, Reindel JF, Bleavins MR, De La Iglesia FA. (2001). RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 33:1239–1258.
   PubMed Web of Science ®Google Scholar
• Burk O, Wojnowski L. (2004). Cytochrome P450 3A and their regulation. Naunyn Schmiedebergs Arch Pharmacol 369:105–124.
   PubMed Web of Science ®Google Scholar
• Cantiello M, Carletti M, Dacasto M, Capolongo F, Gardini G, Cascio P, Martin PGP, Pineau T, Nebbia C. (2006). Catalytic, immunochemical and molecular characterization of xenobiotic-metabolising enzyme modulation by phenobarbital in the bovine liver. J Vet Pharmacol Therap 26 (Suppl 1):109–128.
   Google Scholar
• Cantiello M, Giantin M, Carletti M, Lopparelli RM, Capolongo F, Lasserre F, Bollo E, Nebbia C, Martin PG, Pineau T, Dacasto M. (2009). Effects of dexamethasone, administered for growth promoting purposes, upon the hepatic cytochrome P450 3A expression in the veal calf. Biochem Pharmacol 77:451–463.
   PubMed Web of Science ®Google Scholar
• Chen Y, Goldstein JA. (2009). The transcriptional regulation of the human CYP2C genes. Curr Drug Metab 10:567–578.
   PubMed Web of Science ®Google Scholar
• Chirulli V, Longo V, Marini S, Mazzaccaro A, Fiorio R, Gervasi PG. (2005). CAR and PXR expression and inducibility of CYP2B and CYP3A activities in rat and rabbit lungs. Life Sci 76:2535–2546.
   PubMed Web of Science ®Google Scholar
• Dacasto M, Lopparelli RM, Zancanella V, Giantin M. (2011). Update on CYP genetics in cattle. Proceedings of 17th Biennal AAVPT Symposium, All Molecules Great and Small, May 22–25, Madison, WI, USA, 1–5.
   Google Scholar
• Daly AK. (2006). Significance of the minor cytochrome P450 3A isoforms. Clin Pharmacokinet 45:13–31.
   PubMed Web of Science ®Google Scholar
• Darwish WS, Ikenaka Y, El-Ghareeb WR, Ishizuka M. (2010). High expression of the mRNA of cytochrome P450 and phase II enzymes in the lung and kidney tissues of cattle. Animal 4:2023–2029.
   PubMed Web of Science ®Google Scholar
• Dean S, Tang JI, Seckl JR, Nyirenda MJ. (2010). Developmental and tissue-specific regulation of hepatocyte nuclear factor 4-alpha (HNF4-alpha) isoforms in rodents. Gene Expr 14:337–344.
   PubMed Web of Science ®Google Scholar
• Denison MS, Whitlock JP Jr. (1995). Xenobiotic-inducible transcription of cytochrome P450 genes. J Biol Chem 270:18175–18178.
   PubMed Web of Science ®Google Scholar
• DiMaio Knych HK, McKemnie DS, Stanley SD. (2010). Molecular cloning, expression, and initial characterization of members of the CYP3A family in horses. Drug Metab Dispos 38:1820–1827.
   PubMed Web of Science ®Google Scholar
• Drewes T, Senkel S, Holewa B, Ryffel GU. (1996). Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol Cell Biol 16:925–931.
   PubMed Web of Science ®Google Scholar
• Dunn RT 2nd, Klaassen CD. (1998). Tissue-specific expression of rat sulfotransferase messenger RNAs. Drug Metab Dispos 26:598–604.
   PubMed Web of Science ®Google Scholar
• Ejiri N, Katayama K, Kiyosawa N, Baba Y, Doi K. (2005). Microarray analysis on phase II drug metabolizing enzymes expression in pregnant rats after treatment with pregnenolone-16alpha-carbonitrile or phenobarbital. Exp Mol Pathol 79:272–277.
   PubMed Web of Science ®Google Scholar
• Ferguson SS, LeCluyse EL, Negishi M, Goldstein JA. (2002). Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol Pharmacol 62:737–746.
   PubMed Web of Science ®Google Scholar
• Fink-Gremmels J. (2008). Implications of hepatic cytochrome P450-related biotransformation processes in veterinary sciences. Eur J Pharmacol 585:502–509.
   PubMed Web of Science ®Google Scholar
• Fisher MB, Vandenbranden M, Findlay K, Burchell B, Thummel KE, Hall SD, Wrighton SA. (2000). Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank. Pharmacogenetics 10:727–739.
   PubMedGoogle Scholar
• Forkert PG, D’Costa D, El-Mestrah M. (1999). Expression and inducibility of alpha, pi, and Mu glutathione S-transferase protein and mRNA in murine lung. Am J Respir Cell Mol Biol 20:143–152.
   PubMed Web of Science ®Google Scholar
• Giantin M, Carletti M, Capolongo F, Pegolo S, Lopparelli RM, Gusson F, Nebbia C, Cantiello M, Martin P, Pineau T, Dacasto M. (2008). Effect of breed upon cytochromes P450 and phase II enzyme expression in cattle liver. Drug Metab Dispos 36:885–893.
   PubMed Web of Science ®Google Scholar
• Goriya HV, Kalia A, Bhavsar SK, Joshi CG, Rank DN, Thaker AM. (2005). Comparative evaluation of phenobarbital-induced CYP3A and CYP2H1 gene expression by quantitative RT-PCR in Bantam, Bantamized White Leghorn and White Leghorn chicks. J Vet Sci 6:279–285.
   PubMedGoogle Scholar
• Graham MJ, Lake BG. (2008). Induction of drug metabolism: species differences and toxicological relevance. Toxicology 254:184–191.
   PubMed Web of Science ®Google Scholar
• Graham RA, Tyler LO, Krol WL, Silver IS, Webster LO, Clark P, Chen L, Banks T, LeCluyse EL. (2006). Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes. J Biochem Mol Toxicol 20:69–78.
   PubMed Web of Science ®Google Scholar
• Grasso E, Longo V, Coceani F, Giovanni Gervasi P. (2005). Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle. Biochim Biophys Acta 1722:116–123.
   PubMed Web of Science ®Google Scholar
• Gregory PA, Lewinsky RH, Gardner-Stephen DA, Mackenzie PI. (2004). Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 199:354–363.
   PubMed Web of Science ®Google Scholar
• Handschin C, Meyer UA. (2003). Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev 55:649–673.
   PubMed Web of Science ®Google Scholar
• Honkakoski P, Negishi M. (1997). Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene. J Biol Chem 272:14943–14949.
   PubMed Web of Science ®Google Scholar
• Hukkanen J, Pelkonen O, Raunio H. (2001). Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD. Eur Respir J Suppl 32:122s–126s.
   Google Scholar
• Ioannides C. (2006). Cytochrome p450 expression in the liver of food-producing animals. Curr Drug Metab 7:335–348.
   PubMed Web of Science ®Google Scholar
• Iwano H, Yotsumoto N, Yokota H, Yuasa A. (2001). cDNA cloning and expression of a bovine phenol UDP-glucuronosyltransferase, BovUGT1A6. Life Sci 68:2131–2139.
   PubMed Web of Science ®Google Scholar
• Jarukamjorn K, Sakuma T, Yamamoto M, Ohara A, Nemoto N. (2001). Sex-associated expression of mouse hepatic and renal CYP2B enzymes by glucocorticoid hormones. Biochem Pharmacol 62:161–169.
   PubMed Web of Science ®Google Scholar
• Jiang S, Tanaka T, Iwanari H, Hotta H, Yamashita H, Kumakura J, Watanabe Y, Uchiyama Y, Aburatani H, Hamakubo T, Kodama T, Naito M. (2003). Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4alpha (HNF4alpha) isoforms in human and rats. Nucl Recept 1:5.
   PubMedGoogle Scholar
• Joannard F, Galisteo M, Corcos L, Guillouzo A, Lagadic-Gossmann D. (2000). Regulation of phenobarbital-induction of CYP2B and CYP3A genes in rat cultured hepatocytes: involvement of several serine/threonine protein kinases and phosphatases. Cell Biol Toxicol 16:325–337.
   PubMed Web of Science ®Google Scholar
• Kakizaki S, Yamamoto Y, Ueda A, Moore R, Sueyoshi T, Negishi M. (2003). Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR. Biochim Biophys Acta 1619:239–242.
   PubMed Web of Science ®Google Scholar
• Kawalek JC, el Said KR. (1994). Comparison of maturation of drug-metabolizing enzymes in calves with functioning or nonfunctioning rumen. Am J Vet Res 55:1579–1586.
   PubMed Web of Science ®Google Scholar
• Kiyosawa N, Kwekel JC, Burgoon LD, Dere E, Williams KJ, Tashiro C, Chittim B, Zacharewski TR. (2008). Species-specific regulation of PXR/CAR/ER-target genes in the mouse and rat liver elicited by o, p’-DDT. BMC Genomics 9:487.
   PubMed Web of Science ®Google Scholar
• Klose TS, Blaisdell JA, Goldstein JA. (1999). Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J Biochem Mol Toxicol 13:289–295.
   PubMed Web of Science ®Google Scholar
• Kodama S, Negishi M. (2006). Phenobarbital confers its diverse effects by activating the orphan nuclear receptor CAR. Drug Metab Rev 38:75–87.
   PubMed Web of Science ®Google Scholar
• Kojima H, Sata F, Takeuchi S, Sueyoshi T, Nagai T. (2011). Comparative study of human and mouse pregnane X receptor agonistic activity in 200 pesticides using in vitro reporter gene assays. Toxicology 280:77–87.
   PubMed Web of Science ®Google Scholar
• Krüger KA, Blum JW, Greger DL. (2005). Expression of nuclear receptor and target genes in liver and intestine of neonatal calves fed colostrum and vitamin A. J Dairy Sci 88:3971–3981.
   PubMed Web of Science ®Google Scholar
• Lambert CB, Spire C, Claude N, Guillouzo A. (2009). Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol 234:345–360.
   PubMed Web of Science ®Google Scholar
• Langouët S, Morel F, Meyer DJ, Fardel O, Corcos L, Ketterer B, Guillouzo A. (1996). A comparison of the effect of inducers on the expression of glutathione-S-transferases in the liver of the intact rat and in hepatocytes in primary culture. Hepatology 23:881–887.
   PubMed Web of Science ®Google Scholar
• Larsson P, Persson E, Tydén E, Tjälve H. (2003). Cell-specific activation of aflatoxin B1 correlates with presence of some cytochrome P450 enzymes in olfactory and respiratory tissues in horse. Res Vet Sci 74:227–233.
   PubMed Web of Science ®Google Scholar
• Lee C, Watt KC, Chang AM, Plopper CG, Buckpitt AR, Pinkerton KE. (1998). Site-selective differences in cytochrome P450 isoform activities. Comparison of expression in rat and rhesus monkey lung and induction in rats. Drug Metab Dispos 26:396–400.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408.
   PubMed Web of Science ®Google Scholar
• Longo V, Amato G, Santucci A, Gervasi PG. (1997). Purification and characterization of three constitutive cytochrome P-450 isoforms from bovine olfactory epithelium. Biochem J 323 (Pt 1):65–70.
   PubMedGoogle Scholar
• Lopparelli RM, Zancanella V, Giantin M, Ravarotto L, Cozzi G, Montesissa C, Dacasto M. (2010). Constitutive expression of drug metabolizing enzymes and related transcription factors in cattle testis and their modulation by illicit steroids. Xenobiotica 40:670–680.
   PubMed Web of Science ®Google Scholar
• Lopparelli RM, Zancanella V, Giantin M, Ravarotto L, Pozza G, Montesissa C, Dacasto M. (2011). Steroidogenic enzyme gene expression profiles in the testis of cattle treated with illicit growth promoters. Steroids 76:508–516.
   PubMed Web of Science ®Google Scholar
• Luo G, Guenthner T, Gan LS, Humphreys WG. (2004). CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr Drug Metab 5:483–505.
   PubMed Web of Science ®Google Scholar
• Makino T, Kinoshita J, Arakawa S, Ito K, Ando Y, Yamoto T, Teranishi M, Sanbuissho A, Nakayama H. (2009). Comprehensive analysis of hepatic gene and protein expression profiles on phenobarbital- or clofibrate-induced hepatic hypertrophy in dogs. J Toxicol Sci 34:647–661.
   PubMed Web of Science ®Google Scholar
• Marini S, Nannelli A, Sodini D, Dragoni S, Valoti M, Longo V, Gervasi PG. (2007). Expression, microsomal and mitochondrial activities of cytochrome P450 enzymes in brain regions from control and phenobarbital-treated rabbits. Life Sci 80:910–917.
   PubMed Web of Science ®Google Scholar
• Martignoni M, de Kanter R, Grossi P, Mahnke A, Saturno G, Monshouwer M. (2004). An in vivo and in vitro comparison of CYP induction in rat liver and intestine using slices and quantitative RT-PCR. Chem Biol Interact 151:1–11.
   PubMed Web of Science ®Google Scholar
• Martin P, Riley R, Back DJ, Owen A. (2008). Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells. Br J Pharmacol 153:805–819.
   PubMed Web of Science ®Google Scholar
• Merlanti R, Gallina G, Capolongo F, Contiero L, Biancotto G, Dacasto M, Montesissa C. (2007). An in vitro study on metabolism of 17beta-boldenone and boldione using cattle liver and kidney subcellular fractions. Anal Chim Acta 586:177–183.
   PubMed Web of Science ®Google Scholar
• Mohamed ME, Frye RF. (2011). Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. Planta Med 77:311–321.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, Yokoi T. (2008). Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461–1464.
   PubMed Web of Science ®Google Scholar
• Nannelli A, Chirulli V, Longo V, Gervasi PG. (2008). Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology 252:105–112.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Koeda A, Morikawa H, Satoh T, Narimatsu S, Naito S. (2009). Tissue-specific mRNA expression profiles of drug-metabolizing enzymes and transporters in the cynomolgus monkey. Drug Metab Pharmacokinet 24:139–144.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Naito S. (2006). Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab Pharmacokinet 21:357–374.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Naito S, Yokoi T. (2004). Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. Drug Metab Pharmacokinet 19:135–149.
   PubMedGoogle Scholar
• Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. (2003). Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 123:369–375.
   PubMed Web of Science ®Google Scholar
• Olinga P, Elferink MG, Draaisma AL, Merema MT, Castell JV, Pérez G, Groothuis GM. (2008). Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. Eur J Pharm Sci 33:380–389.
   PubMed Web of Science ®Google Scholar
• Pavek P, Dvorak Z. (2008). Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 9:129–143.
   PubMed Web of Science ®Google Scholar
• Pegolo S, Merlanti R, Giantin M, Dacasto M, Montesissa C, Capolongo F. (2010). High performance liquid chromatography determination of cytochrome P450 1A and 2C activities in bovine liver microsomes. Vet J 183:81–88.
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H. (2008). Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 82:667–715.
   PubMed Web of Science ®Google Scholar
• Puccinelli E, Gervasi PG, La Marca M, Beffy P, Longo V. (2010). Expression and inducibility by phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22, and CYP3As in porcine liver, kidney, small intestine, and nasal tissues. Xenobiotica 40:525–535.
   PubMed Web of Science ®Google Scholar
• Pustylnyak VO, Gulyaeva LF, Lyakhovich VV. (2005). CAR expression and inducibility of CYP2B genes in liver of rats treated with PB-like inducers. Toxicology 216:147–153.
   PubMed Web of Science ®Google Scholar
• Pustylnyak V, Pivovarova E, Slynko N, Gulyaeva L, Lyakhovich V. (2009). Species-specific induction of CYP2B by 2,4,6-tryphenyldioxane-1,3 (TPD). Life Sci 85:815–821.
   PubMed Web of Science ®Google Scholar
• Raunio H, Hakkola J, Pelkonen O. (2005). Regulation of CYP3A genes in the human respiratory tract. Chem Biol Interact 151:53–62.
   PubMed Web of Science ®Google Scholar
• Riches Z, Stanley EL, Bloomer JC, Coughtrie MW. (2009). Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT “pie”. Drug Metab Dispos 37:2255–2261.
   PubMed Web of Science ®Google Scholar
• Robinson TL, Sutherland IA, Sutherland J. (2007). Validation of candidate bovine reference genes for use with real-time PCR. Vet Immunol Immunopathol 115:160–165.
   PubMed Web of Science ®Google Scholar
• Romero L, Ng L, Kirby GM. (2006). Chemical inducers of rodent glutathione s-transferases down-regulate human GSTA1 transcription through a mechanism involving variant hepatic nuclear factor 1-C. Mol Pharmacol 70:277–286.
   PubMed Web of Science ®Google Scholar
• Rowe JD, Nieves E, Listowsky I. (1997). Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem J 325 (Pt 2):481–486.
   PubMedGoogle Scholar
• Runge-Morris M, Rose K, Falany CN, Kocarek TA. (1998). Differential regulation of individual sulfotransferase isoforms by phenobarbital in male rat liver. Drug Metab Dispos 26:795–801.
   PubMed Web of Science ®Google Scholar
• Seliskar M, Rozman D. (2007). Mammalian cytochromes P450– importance of tissue specificity. Biochim Biophys Acta 1770:458–466.
   PubMed Web of Science ®Google Scholar
• Shang H, Yang J, Liu Y, Wei H. (2009). Tissue distribution of CYP3A29 mRNA expression in Bama miniature pig by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Xenobiotica 39:423–429.
   PubMed Web of Science ®Google Scholar
• Shelby MK, Cherrington NJ, Vansell NR, Klaassen CD. (2003). Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab Dispos 31:326–333.
   PubMed Web of Science ®Google Scholar
• Shelby MK, Klaassen CD. (2006). Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways. Drug Metab Dispos 34:1772–1778.
   PubMed Web of Science ®Google Scholar
• Skarin T, Becher R, Bucht A, Duvefelt K, Bohm S, Ranneberg-Nilsen T, Lilleaas EM, Schwarze PE, Toftgârd R. (1999). Cis-acting sequences from the rat cytochrome P450 2B1 gene confer pulmonary and phenobarbital-inducible expression in transgenic mice. Am J Respir Cell Mol Biol 21:177–184.
   PubMed Web of Science ®Google Scholar
• Smith CM, Faucette SR, Wang H, LeCluyse EL. (2005). Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers. J Biochem Mol Toxicol 19:96–108.
   PubMed Web of Science ®Google Scholar
• Strott CA. (2002). Sulfonation and molecular action. Endocr Rev 23:703–732.
   PubMed Web of Science ®Google Scholar
• Sugatani J, Kojima H, Ueda A, Kakizaki S, Yoshinari K, Gong QH, Owens IS, Negishi M, Sueyoshi T. (2001). The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33:1232–1238.
   PubMed Web of Science ®Google Scholar
• Tamasi V, Juvan P, Beer M, Rozman D, Meyer UA. (2009). Transcriptional activation of PPARalpha by phenobarbital in the absence of CAR and PXR. Mol Pharm 6:1573–1581.
   PubMedGoogle Scholar
• Thelen K, Dressman JB. (2009). Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol 61:541–558.
   PubMed Web of Science ®Google Scholar
• Timsit YE, Negishi M. (2007). CAR and PXR: the xenobiotic-sensing receptors. Steroids 72:231–246.
   PubMed Web of Science ®Google Scholar
• Toffolatti L, Rosa Gastaldo L, Patarnello T, Romualdi C, Merlanti R, Montesissa C, Poppi L, Castagnaro M, Bargelloni L. (2006). Expression analysis of androgen-responsive genes in the prostate of veal calves treated with anabolic hormones. Domest Anim Endocrinol 30:38–55.
   Google Scholar
• Tolson AH, Wang H. (2010). Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev 62:1238–1249.
   PubMed Web of Science ®Google Scholar
• Tsao CC, Coulter SJ, Chien A, Luo G, Clayton NP, Maronpot R, Goldstein JA, Zeldin DC. (2001). Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products. J Pharmacol Exp Ther 299:39–47.
   PubMed Web of Science ®Google Scholar
• Tsoi C, Morgenstern R, Swedmark S. (2002). Canine sulfotransferase SULT1A1: molecular cloning, expression, and characterization. Arch Biochem Biophys 401:125–133.
   PubMed Web of Science ®Google Scholar
• Uno Y, Matsuno K, Nakamura C, Utoh M, Yamazaki H. (2009). Cloning, expression, and characterization of CYP3A43 cDNA in cynomolgus macaque (Macaca fascicularis). Drug Metab Lett 3:228–233.
   PubMedGoogle Scholar
• van de Kerkhof EG, de Graaf IA, de Jager MH, Groothuis GM. (2007). Induction of phase I and II drug metabolism in rat small intestine and colon in vitro. Drug Metab Dispos 35:898–907.
   PubMed Web of Science ®Google Scholar
• van de Kerkhof EG, de Graaf IA, Ungell A-LB, Groothuis GM. (2008). Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro. Drug Metab Dispos 36:604–613.
   PubMed Web of Science ®Google Scholar
• van’t Klooster GA, Horbach GJ, Natsuhori M, Blaauboer BJ, Noordhoek J, van Miert AS. (1993). Hepatic cytochrome P450 induction in goats. Effects of model inducers on the metabolism of alkoxyresorufins, testosterone and ethylmorphine, and on apoprotein and mRNA levels. Biochem Pharmacol 45:113–122.
   PubMed Web of Science ®Google Scholar
• Virkel G, Carletti M, Cantiello M, Della Donna L, Gardini G, Girolami F, Nebbia C. (2010). Characterization of xenobiotic metabolizing enzymes in bovine small intestinal mucosa. J Vet Pharmacol Ther 33:295–303.
   PubMed Web of Science ®Google Scholar
• Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M. (2005). CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42:420–430.
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Azaroff L. (1992). Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281 (Pt 3):577–592.
   PubMedGoogle Scholar
• Wojnowski L. (2004). Genetics of the variable expression of CYP3A in humans. Ther Drug Monit 26:192–199.
   PubMed Web of Science ®Google Scholar
• Xu C, Li CY, Kong AN. (2005). Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249–268.
   PubMed Web of Science ®Google Scholar
• Xu C, Wang X, Staudinger JL. (2009). Regulation of tissue-specific carboxylesterase expression by pregnane x receptor and constitutive androstane receptor. Drug Metab Dispos 37:1539–1547.
   PubMed Web of Science ®Google Scholar
• Yamada H, Ishii Y, Yamamoto M, Oguri K. (2006). Induction of the hepatic cytochrome P450 2B subfamily by xenobiotics: research history, evolutionary aspect, relation to tumorigenesis, and mechanism. Curr Drug Metab 7:397–409.
   PubMed Web of Science ®Google Scholar
• Yang SP, Medling T, Raner GM. (2003). Cytochrome P450 expression and activities in rat, rabbit and bovine tongue. Comp Biochem Physiol C Toxicol Pharmacol 136:297–308.
   PubMed Web of Science ®Google Scholar
• Zancanella V, Giantin M, Lopparelli RM, Patarnello T, Dacasto M, Negrisolo E. (2010). Proposed new nomenclature for Bos taurus cytochromes P450 involved in xenobiotic drug metabolism. J Vet Pharmacol Ther 33:528–536.
   PubMed Web of Science ®Google Scholar
• Zhang H, LeCulyse E, Liu L, Hu M, Matoney L, Zhu W, Yan B. (1999). Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch Biochem Biophys 368:14–22.
   PubMed Web of Science ®Google Scholar
• Zhang QY, Dunbar D, Kaminsky LS. (2003). Characterization of mouse small intestinal cytochrome P450 expression. Drug Metab Dispos 31:1346–1351.
   PubMed Web of Science ®Google Scholar
• Zheng JL, Parfett C, Williams A, Yagminas A, Zhou G, Douglas GR, Yauk CL. (2011). Assessment of subclinical, toxicant-induced hepatic gene expression profiles after low-dose, short-term exposures in mice. Regul Toxicol Pharmacol 60:54–72.
   PubMed Web of Science ®Google Scholar